<DOC>
	<DOCNO>NCT02731105</DOCNO>
	<brief_summary>Study compare two gel use treat acne vulgaris . It compare tolerability effectivity follow application two combination topical acne product clindamycin 1 % 0.025 % tretinoin gel ( Acnatac® Gel ) , adapalen 0,1 % benzoyl peroxide 2,5 % gel ( Epiduo® Gel ) .</brief_summary>
	<brief_title>Pilot Study Tolerability Effectivity Two Combination Topical Acne Products</brief_title>
	<detailed_description>At baseline , data collect regard demographic medical/medication history , lesion count medical examination do . Female patient could pregnant test use pregnancy test . Each patient receive two tubes different medication apply left right side face home day ( Acnatac® Gel , Duac® Gel , Epiduo® Gel ) . Patients study-center staff instruct reveal treatment allocation investigator , patient instruct apply product presence Follow-up visit conduct day 0 , 7 21 . On day investigator measure erythema dryness/scaling use Investigators´Global Assessment , severity burning/ sting itch use Study Subject Self-Assessment , record number acneiform lesion , measure health-related quality life use DLQI-Score , skin hydration use Corneometer , transepidermal water loss ( TEWL ) use Tewameter® , skin surface pH use pH-Meter skin sebum excretion use Sebumeter . On day 0 , 7 , 21 collect information current use medication . Adverse event ( AEs ) serious adverse event ( SAEs ) monitor visit . On day 21 make last pregnancy test . Checking compliance make regularly .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Adapalene , Benzoyl Peroxide Drug Combination</mesh_term>
	<criteria>Diagnosis mild moderate facial acne vulgaris baseline Age : 14 year 50 year No evidence facial irritation ( erythema , dryness/scaling , burning/itching/stinging ) typical acne vulgaris Willingness take part acne study include screen visit follow visit day 0,7 , 21 No use systemic antibiotic , steroid , retinoids keratolytics within last 30 day start acne study Patients sign personally consent form follow study procedure Patient good general health Female patient pregnant , plan become pregnant breastfeed Sexually active female subject use medically acceptable form contraception ( oral contraception , injectable implantable method intrauterine device ) Female patient childbearing year except postmenopausal ( 12 month natural amenorrhoea ) , ▪ postoperative ( 6 week ovariectomy without hysterectomy ) regularly correct use contraceptive error rate &lt; 1 % /year sex vasectomy partner Diseases facial skin acne No concomitant topical medication ( include makeup ) keratolytics sulphur , salicylic acid , benzoyl peroxide , resorcin abradents acidcontaining peel one week study start Patients facial procedure ( chemical peel , laser therapy , photodynamic therapy , microdermabrasion , UV light therapy ) within past 4 week No concomitant participation study within past 30 day Hypersensitivity ingredient Acnatac® gel Epiduo®gel Systemic medication antibiotic antibiotic within last 4 week study start Systemic medication retinoids within last 6 month study start Topical treatment acne vulgaris within last two week study Acne fulminans , Severe systemic disease respectively take immunosuppressive drug Severe liver disease Severe renal disease History presence regional enteritis inflammatory bowel disease Other reason doctor charge decides</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>acne</keyword>
	<keyword>vulgaris</keyword>
	<keyword>Clindamycin</keyword>
	<keyword>Tretinoin</keyword>
	<keyword>Adapalen</keyword>
	<keyword>Benzoylperoxid</keyword>
	<keyword>Epiduo</keyword>
	<keyword>Acnatac</keyword>
</DOC>